199 related articles for article (PubMed ID: 32811866)
1. ENaC regulation by phospholipids and DGK explained through mathematical modeling.
Olivença DV; Voit EO; Pinto FR
Sci Rep; 2020 Aug; 10(1):13952. PubMed ID: 32811866
[TBL] [Abstract][Full Text] [Related]
2. A Mathematical Model of the Phosphoinositide Pathway.
Olivença DV; Uliyakina I; Fonseca LL; Amaral MD; Voit EO; Pinto FR
Sci Rep; 2018 Mar; 8(1):3904. PubMed ID: 29500467
[TBL] [Abstract][Full Text] [Related]
3. Thickness of the airway surface liquid layer in the lung is affected in cystic fibrosis by compromised synergistic regulation of the ENaC ion channel.
Olivença DV; Fonseca LL; Voit EO; Pinto FR
J R Soc Interface; 2019 Aug; 16(157):20190187. PubMed ID: 31455163
[TBL] [Abstract][Full Text] [Related]
4. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).
Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK
J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
Mroz MS; Harvey BJ
Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
[TBL] [Abstract][Full Text] [Related]
6. The CFTR and ENaC debate: how important is ENaC in CF lung disease?
Collawn JF; Lazrak A; Bebok Z; Matalon S
Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1141-6. PubMed ID: 22492740
[TBL] [Abstract][Full Text] [Related]
7. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis.
Shei RJ; Peabody JE; Kaza N; Rowe SM
Curr Opin Pharmacol; 2018 Dec; 43():152-165. PubMed ID: 30340955
[TBL] [Abstract][Full Text] [Related]
8. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
[TBL] [Abstract][Full Text] [Related]
9. Increased apical Na+ permeability in cystic fibrosis is supported by a quantitative model of epithelial ion transport.
O'Donoghue DL; Dua V; Moss GW; Vergani P
J Physiol; 2013 Aug; 591(15):3681-92. PubMed ID: 23732645
[TBL] [Abstract][Full Text] [Related]
10. Liquid movement across the surface epithelium of large airways.
Chambers LA; Rollins BM; Tarran R
Respir Physiol Neurobiol; 2007 Dec; 159(3):256-70. PubMed ID: 17692578
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytosolic pH on epithelial Na+ channel in normal and cystic fibrosis sweat ducts.
Reddy MM; Wang XF; Quinton PM
J Membr Biol; 2008; 225(1-3):1-11. PubMed ID: 18937003
[TBL] [Abstract][Full Text] [Related]
12. Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.
Gianotti A; Melani R; Caci E; Sondo E; Ravazzolo R; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):445-52. PubMed ID: 23600628
[TBL] [Abstract][Full Text] [Related]
13. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
14. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
[TBL] [Abstract][Full Text] [Related]
15. ENaC inhibitors for the treatment of cystic fibrosis.
Butler R; Hunt T; Smith NJ
Pharm Pat Anal; 2015 Jan; 4(1):17-27. PubMed ID: 25565157
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung.
Lazrak A; Jurkuvenaite A; Chen L; Keeling KM; Collawn JF; Bedwell DM; Matalon S
Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L557-67. PubMed ID: 21743028
[TBL] [Abstract][Full Text] [Related]
17. Epithelial sodium channel inhibition in primary human bronchial epithelia by transfected siRNA.
Caci E; Melani R; Pedemonte N; Yueksekdag G; Ravazzolo R; Rosenecker J; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):211-6. PubMed ID: 18723440
[TBL] [Abstract][Full Text] [Related]
18. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art.
Althaus M
Curr Mol Pharmacol; 2013 Mar; 6(1):3-12. PubMed ID: 23547930
[TBL] [Abstract][Full Text] [Related]
19. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.
Wagner CA; Ott M; Klingel K; Beck S; Melzig J; Friedrich B; Wild KN; Bröer S; Moschen I; Albers A; Waldegger S; Tümmler B; Egan ME; Geibel JP; Kandolf R; Lang F
Cell Physiol Biochem; 2001; 11(4):209-18. PubMed ID: 11509829
[TBL] [Abstract][Full Text] [Related]
20.
Saber A; Nakka SS; Hussain R; Hugosson S
Acta Otolaryngol; 2019 Jul; 139(7):652-658. PubMed ID: 31050570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
